The Memory Shield: New Dual-Target Antibody Halts Alzheimer’s Progression in Landmark Trial
A groundbreaking Phase 3 clinical trial reveals that a new dual-target monoclonal antibody has halted cognitive decline ...
Read More →Health and wellness news.
A groundbreaking Phase 3 clinical trial reveals that a new dual-target monoclonal antibody has halted cognitive decline ...
Read More →Pakistan reached a historic health milestone on June 16, 2026, recording zero new polio cases for the year. This success...
Read More →